GJA1 and chronic kidney disease: This overexpression was deleterious since genetic and pharmacogenetic inhibition of Cx43, improved renal structure and function by inhibiting inflammation and further interstitial renal fibrosis in different models of experimental CKD (Abed et al. 2014; Kavvadas et al. 2017).